Product
Supplier
Encyclopedia
Inquiry
Upadacitinib 98% buy - large image1
Upadacitinib 98% buy - image1

Upadacitinib 98%

GMP 14 Inquiries

Unit Price: Get Latest Price
CAS No.:

1310726-60-3

Grade:

Pharmaceutical Grade

Content:

98%

Port:

Shanghai

Packaging:

25kg/drum

Price valid (until):

2024-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

APIs,Veterinary,Cosmetic Ingredients,Peptides,intermediates,food ingredients

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Upadacitinib (ABT-494) is a Janus kinase 1 (JAK1) inhibitor currently being developed by AbbVie for the treatment of rheumatoid arthritis (RA), Crohn’s disease, ulcerative colitis, atopic dermatitis, and psoriatic arthritis. It is also being investigated as a potential treatment for people with active ankylosing spondylitis (AS).

    Items Specifications






    Certificates

    Basic Info
    Product Name:

    (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide

    CAS No.:

    1310726-60-3

    Molecular Formula:

    C17H19F3N6O

    InChIKeys:

    InChIKey=WYQFJHHDOKWSHR-MNOVXSKESA-N

    Molecular Weight:

    380.368

    Exact Mass:

    380.37

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    78.32

    XLogP3:

    3.2367

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    APIs,Veterinary,Cosmetic Ingredients,Peptides,intermediates,food ingredients

    Location:

    T2-805,European and American Financial City,Cangqian Street,Yuhang District,Hangzhou,China.(zip code:311121)

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    20

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2009

    Hangzhou Holypharm Biotech Co., Ltd was founded in Hangzhou in 2006. Over the decades, Holypharm has maintained sound development and rapid global expansion. Based on China and looking at the world, the Holypharm has become a leading professional health industry chain service group in China.

     

    Holypharm supplies different kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, intermediates, food additives, natural nutrition ingredients, feed additives, cosmetic additives, , medical devices, etc. Based on the deep strategic cooperation with Brightgene Pharmaceutical Company, and integrated production advantages, Holypharm's marketing network has spread over more than 40 countries and regions on five continents, providing professional service for global customers.

     

    With a commitment to quality and customer satisfaction, Holypharm has become a trusted name in the industry. Our strong product line includes like a range of high-quality tripeptide copper, (±)-Lipoic acid in cosmetics, Sameglutide Tirzepatide in the field of metabolism which are available at competitive prices. Holypharm has established itself as a reliable supplier of chemical products on the echemi.com.

     

    In the future, Holypharm will expand its business in the CDMO and OEM industry, connect the investment, R&D and production, and gradually become a integrated enterprise. Holypharm will stay true to the mission of serving the global health industry and helping create a win-win situation.


  • Inquiry History
    14 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Upadacitinib

    30.00 KG May 20, 2024
    India

    Upadacitinib - ABT- 494

    5.00 KG Jan 19, 2024
    India

    Upadacitinib

    5 KG Jan 17, 2024
    India

    Upadacitinib

    10.00 KG Mar 6, 2024
    Hongkong, China

    Upadacitinib

    50 MG Apr 7, 2026
    India

    Upadacitinib

    100 G Nov 24, 2025
    India

    Upadacitinib

    5 KG Nov 29, 2023
    Pakistan

    UPADACITINIB

    7 KG Oct 8, 2023
    Pakistan

    UPADACITINIB

    0.51 KG Feb 25, 2026
    India

    Upadacitinib

    1000.00 KG Feb 13, 2025
    Pakistan

    Upadacitinib

    1 KG Feb 17, 2025
    India

    Ripretinib

    10.00 KG Mar 6, 2024
    India

    URSODEOXYCHOLIC ACID

    10.00 KG Mar 6, 2024
    India

    Acarbose

    10.00 KG Mar 6, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.